Uzun and colleagues described the use of anti-IgE antibody in addition to standard rescue therapy to treat a patient with a past medical history (PMH) of Hepatitis C (HCV) who developed SJS-TEN after receiving one dose of levofloxacin [63]. The gene discussed is IGHE; the disease is toxic epidermal necrolysis.